These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3497760)

  • 1. Interstitial lung disease as the presentation of anti-Jo-1 positive polymyositis.
    Nash P; Schrieber L; Webb J
    Clin Rheumatol; 1987 Jun; 6(2):282-6. PubMed ID: 3497760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody to Jo-1 in polymyositis/dermatomyositis: association with interstitial pulmonary disease.
    Hochberg MC; Feldman D; Stevens MB; Arnett FC; Reichlin M
    J Rheumatol; 1984 Oct; 11(5):663-5. PubMed ID: 6334746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interstitial alveolitis as early manifestation of anti-Jo-1 positive polymyositis.
    Löhr HF; Böcher WO; Hermann E; Müller-Quernheim J; Schwickert H; Meyer zum Büschenfelde KH; Gerken G
    Z Rheumatol; 1993; 52(5):307-11. PubMed ID: 8259723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The precipitating antibody to an acidic nuclear protein antigen, the Jo-1, in connective tissue diseases. A marker for a subset of polymyositis with interstitial pulmonary fibrosis.
    Yoshida S; Akizuki M; Mimori T; Yamagata H; Inada S; Homma M
    Arthritis Rheum; 1983 May; 26(5):604-11. PubMed ID: 6405755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization and peripheral blood biomarker assessment of anti-Jo-1 antibody-positive interstitial lung disease.
    Richards TJ; Eggebeen A; Gibson K; Yousem S; Fuhrman C; Gochuico BR; Fertig N; Oddis CV; Kaminski N; Rosas IO; Ascherman DP
    Arthritis Rheum; 2009 Jul; 60(7):2183-92. PubMed ID: 19565490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical implications of autoantibody screening in patients with autoimmune myositis.
    Ghirardello A; Zampieri S; Tarricone E; Iaccarino L; Bendo R; Briani C; Rondinone R; Sarzi-Puttini P; Todesco S; Doria A
    Autoimmunity; 2006 May; 39(3):217-21. PubMed ID: 16769655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary fibrosis with predominant CD8 lymphocytic alveolitis and anti-Jo-1 antibodies.
    Sauty A; Rochat T; Schoch OD; Hamacher J; Kurt AM; Dayer JM; Nicod LP
    Eur Respir J; 1997 Dec; 10(12):2907-12. PubMed ID: 9493684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Polymyositis and Jo-1 syndrome].
    Treher E; Niederhoff A; Gellissen U; Schmidt P; Dornberg M; Peter HH
    Z Rheumatol; 1993; 52(5):301-6. PubMed ID: 8259722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Jo-1 antibody in patients with polymyositis/dermatomyositis.
    Leu CC; Lan JL
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1992 Feb; 25(1):41-7. PubMed ID: 1306148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anti-Jo-1 antibodies: specific autoantibodies for polymyositis with interstitial pulmonary fibrosis. 2 case reports].
    Fischer E; Thiele A; Stierle HE; Lang B
    Z Rheumatol; 1995; 54(3):171-7. PubMed ID: 7660688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features and outcomes of interstitial lung disease in anti-Jo-1 positive antisynthetase syndrome.
    Zamora AC; Hoskote SS; Abascal-Bolado B; White D; Cox CW; Ryu JH; Moua T
    Respir Med; 2016 Sep; 118():39-45. PubMed ID: 27578469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Jo-1 antibodies.
    Zampieri S; Ghirardello A; Iaccarino L; Tarricone E; Gambari PF; Doria A
    Autoimmunity; 2005 Feb; 38(1):73-8. PubMed ID: 15804708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antisynthetase syndrome presenting as interstitial lung disease: a case report.
    Badshah A; Haider I; Pervez S; Humayun M
    J Med Case Rep; 2019 Aug; 13(1):241. PubMed ID: 31376837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymyositis and pulmonary fibrosis associated with anti-PL-7 antibody.
    LaMedica G; Parodi A; Peris G; Rebora A
    J Am Acad Dermatol; 1988 Sep; 19(3):567-8. PubMed ID: 3262633
    [No Abstract]   [Full Text] [Related]  

  • 15. The Jo-1 antibody system in myositis: relationships to clinical features and HLA.
    Arnett FC; Hirsch TJ; Bias WB; Nishikai M; Reichlin M
    J Rheumatol; 1981; 8(6):925-30. PubMed ID: 6977032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preliminary report on the clinical application of anti-Jo-1 antibody].
    Dong Y; Cheng PC; Zhang NC
    Zhonghua Nei Ke Za Zhi; 1989 Jun; 28(6):368-9, 383. PubMed ID: 2582917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of B-cell activating factor of the TNF family (BAFF) correlate with anti-Jo-1 autoantibodies levels and disease activity in patients with anti-Jo-1positive polymyositis and dermatomyositis.
    Kryštůfková O; Hulejová H; Mann HF; Pecha O; Půtová I; Ekholm L; Lundberg IE; Vencovský J
    Arthritis Res Ther; 2018 Jul; 20(1):158. PubMed ID: 30053824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Jo-1 antibody: a marker for myositis with interstitial lung disease.
    Bernstein RM; Morgan SH; Chapman J; Bunn CC; Mathews MB; Turner-Warwick M; Hughes GR
    Br Med J (Clin Res Ed); 1984 Jul; 289(6438):151-2. PubMed ID: 6430389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The anti-Jo-1 syndrome - a specific form of myositis with interstitial lung disease].
    Häussermann A; Gillissen A; Seidel W
    Pneumologie; 2010 Aug; 64(8):496-503. PubMed ID: 20387195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interstitial lung disease and cryoglobulinemia in polymyositis.
    Lambie PB; Quismorio FP
    J Rheumatol; 1991 Mar; 18(3):468-9. PubMed ID: 1856818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.